Companies
Company Logo
Oneliner
Company Logo
Oneliner
Add Entity
snc-logo

Startup Nation Finder

Ecosystem
Startups
Investors
Hubs
Multinationals
Reports toggle reports submenu
My Watchlists
My Saved Searches
Following
Inbox
About Us
Glossary

snackbar-icon
title

Create new Watchlist

Watchlist name*
Watchlist must have a valid name.
Description (optional)
Notifications Off
Public content (accessible by all Finder users)

Add to watchlist

    Hey #USER_FULLNAME#!
    Claim #COMPANY_NAME#’s profile to become an administrator with editing privileges in
    #COMPANY_NAME#’s page on Startup Nation Finder

    The invitation to claim the profile was originally sent to

    or  

    Hey #USER_FULLNAME#!
    Claim #COMPANY_NAME#’s profile to become an administrator with editing privileges in
    #COMPANY_NAME#’s page on Startup Nation Finder

    Suggest Edits

    Let us know what you think is inaccurate or missing.
    We will check it out and update the profile if needed.

    Claim Profile

    Please provide us the following information. Note that you need to have an email in this organization in order to claim the profile.

    Already have an account? Login

    Verify your email

    We’ve sent a verification link to [email protected]
    Reset password
    Don't have an account? Sign up

    Check your mailbox

    We sent you an email with further instructions to
    [email protected]

    Do not forget to check your spam folder

    Didn’t get the email? Resend email or Contact us

    Password must contain at least 8 characters, one digit, one uppercase and one lowercase letter.

    Save Search

    Search must have a valid name.

    Rename Search

    Search must have a valid name.
    Delete Saved Search Confirmation
    search will be permanently removed from Finder.
    News Analysis
    Search Startups

    Pre-Seed/Acquired, Tagged as ('biopharmaceutical') Startups

    Filters
    Clear

    Search by tag (1)

    All of
    Any of
    None of

    Sector 

    Primary Sector 

    Target Customer 

    Core Technology 

    Funding Stage (2)

    Founded 

    Total Raised 

    Min
    Max

    Market Cap 

    Min
    Max

    Business Models 

    Product Stage 

    Employees 

    Location 

    Status 

    11 Startups 0 In the News 3 Recently Updated
    • Total Funding
      $266.18M
      Raised
      17
      Events
    • Private Funding
      $159.38M
      Raised
      11
      Rounds
    • Public Offerings
      $0
      Raised
      0
      Offerings
    • M&A
      $106.8M
      Raised
      6
      Deals
    Funding
    Number of Employees
    Rounds / Deals
    Funding Stage
    Tags

    There aren’t any companies that match your search
    you can try looking for something else.

    Fibplant logo

    Fibplant

    Genetically Engineered Fibrin Sealant
    2019 B2B 1-10 Pre-Seed Undisclosed
    biological-therapy
    molecular-biology
    drug-development
    plant-genomics
    life-sciences
    genetic-engineering
    bioprocess
    biopharmaceutical
    pharmaceuticals
    plant-protein
    biotechnology
    surgery
    Viritis logo

    Viritis

    Cellular Protection From Any Virus
    2020 B2B, B2B2C 1-10 Pre-Seed $50K
    pharmaceuticals
    vaccines
    oral-drugs
    therapeutics
    drug-delivery
    treatments
    viral-diseases
    biotechnology
    biopharmaceutical
    drug-design
    nanotechnology
    Datum Dental logo

    Datum Dental

    Presumed Inactive
    ?
    Based on data collected from different sources by our team,
    there are indicators that suggest that this company is no longer active. However, this information may not be accurate. If you believe this information should be updated, please .
    For more details, you can read our .
    Dental Biomaterial Products for Tissue and Bone Regeneration
    2012 B2B 11-50 Acquired Undisclosed
    biotechnology
    biopharmaceutical
    medical-technologies
    dentists
    tissue-regeneration
    regenerative-medicine
    dental
    medical-devices
    TyrNovo logo

    TyrNovo

    Presumed Inactive
    ?
    Based on data collected from different sources by our team,
    there are indicators that suggest that this company is no longer active. However, this information may not be accurate. If you believe this information should be updated, please .
    For more details, you can read our .
    Targeted Therapy to Prevent Resistance to Cancer Drugs
    2013 B2B 1-10 Acquired Undisclosed
    cancer
    personalization
    biopharmaceutical
    drug-discovery
    oncology
    pharma-companies
    Applied Immune Technologies logo

    Applied Immune Technologies

    Presumed Inactive
    ?
    Based on data collected from different sources by our team,
    there are indicators that suggest that this company is no longer active. However, this information may not be accurate. If you believe this information should be updated, please .
    For more details, you can read our .
    TCRL Antibodies for Therapeutic Applications
    2006 B2B 1-10 Acquired $4.4M
    viral-diseases
    cancer
    antibodies
    biotechnology
    biopharmaceutical
    therapeutics
    diagnostics
    autoimmune-diseases
    patients
    doctors
    BioSight logo

    BioSight

    Presumed Inactive
    ?
    Based on data collected from different sources by our team,
    there are indicators that suggest that this company is no longer active. However, this information may not be accurate. If you believe this information should be updated, please .
    For more details, you can read our .
    Therapeutics for Oncology and Hematological Disorders
    1999 B2B 1-10 Acquired $62.5M
    chemotherapy
    cancer
    drug-discovery
    biopharmaceutical
    targeted-therapy
    pharmaceuticals
    cancer-therapy
    oncology
    hematology
    BTG logo

    BTG

    Acquired
    Genetically Engineered Drugs
    1980 B2B2C 201-500 Acquired $26.93M
    eye-diseases
    ophthalmology
    genetic-engineering
    osteoarthritis
    biotechnology
    biopharmaceutical
    patients
    pharma-companies

    Notifications settings

    Off
    Frequency:
    Select all

    Search Startups

    11 Results
    Funding Amount
    Funding Stages
    • Total Funding
      $266.18M
      Raised
      17
      Events
    • Private Funding
      $159.38M
      Raised
      11
      Rounds
    • Public Offerings
      $0
      Raised
      0
      Offerings
    • M&A
      $106.8M
      Raised
      6
      Deals

    Funding

    Rounds / Deals

    Funding Stage

    Number of Employees

    There aren’t any companies that match your search
    you can try looking for something else.

    Fibplant logo
    Raised
    Undisclosed
    Fibplant
    Genetically Engineered Fibrin Sealant
    Founded:2019
    Business Model:B2B
    Employees:1-10
    Funding Stage:Pre-Seed
    Viritis logo
    Raised
    $50K
    Viritis
    Cellular Protection From Any Virus
    Founded:2020
    Business Model:B2B, B2B2C
    Employees:1-10
    Funding Stage:Pre-Seed
    Datum Dental logo
    Raised
    Undisclosed
    Datum Dental
    Presumed Inactive
    ?
    Based on data collected from different sources by our team,
    there are indicators that suggest that this company is no longer active. However, this information may not be accurate. If you believe this information should be updated, please .
    For more details, you can read our .
    Dental Biomaterial Products for Tissue and Bone Regeneration
    Founded:2012
    Business Model:B2B
    Employees:11-50
    Funding Stage:Acquired
    TyrNovo logo
    Raised
    Undisclosed
    TyrNovo
    Presumed Inactive
    ?
    Based on data collected from different sources by our team,
    there are indicators that suggest that this company is no longer active. However, this information may not be accurate. If you believe this information should be updated, please .
    For more details, you can read our .
    Targeted Therapy to Prevent Resistance to Cancer Drugs
    Founded:2013
    Business Model:B2B
    Employees:1-10
    Funding Stage:Acquired
    Applied Immune Technologies logo
    Raised
    $4.4M
    Applied Immune Technologies
    Presumed Inactive
    ?
    Based on data collected from different sources by our team,
    there are indicators that suggest that this company is no longer active. However, this information may not be accurate. If you believe this information should be updated, please .
    For more details, you can read our .
    TCRL Antibodies for Therapeutic Applications
    Founded:2006
    Business Model:B2B
    Employees:1-10
    Funding Stage:Acquired
    BioSight logo
    Raised
    $62.5M
    BioSight
    Presumed Inactive
    ?
    Based on data collected from different sources by our team,
    there are indicators that suggest that this company is no longer active. However, this information may not be accurate. If you believe this information should be updated, please .
    For more details, you can read our .
    Therapeutics for Oncology and Hematological Disorders
    Founded:1999
    Business Model:B2B
    Employees:1-10
    Funding Stage:Acquired
    BTG logo
    Raised
    $26.93M
    BTG
    Acquired
    Genetically Engineered Drugs
    Founded:1980
    Business Model:B2B2C
    Employees:201-500
    Funding Stage:Acquired
    Unlock financial data
    Finder is provided for free by the non-profit organization Startup Nation Central.
    • Get unlimited search results
    • Save to custom lists - Watchlists
    • Get notified with news and updates
    • Connect with people
    And much more...
    I already have access,
    I already have access,